OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
September 23, 2020
A Phase III trial to evaluate safety and efficacy of Janssen’s COVID-19 vaccine candidate, JNJ-78436735, also known as Ad26.COV2.S, is enrolling participants on three continents.
September 17, 2020
The Russian Direct Investment Fund has announced three deals with India, Brazil, and Mexico, for the supply of doses of Sputnik V, a potential COVID-19 vaccine.
September 16, 2020
Polymeric containers offer an alternative to glass.
September 13, 2020
Clinical trials for AZD1222 coronavirus vaccine resume in the UK as per guidance by MHRA.
September 08, 2020
The clinical trials of the AstraZeneca Oxford COVID-19 vaccine, AZD1222, have been paused for a safety review as a result of an incident of an unexplained illness in a UK trial patient.
As public confidence in the drug development process waivers, leading vaccine developers promise to adhere to scientific and regulatory principles.
September 03, 2020
Rapid scale-up to billions of doses requires collaborative, all-out efforts by innovators, their manufacturing partners, and the entire supply chain.
Tight development timelines and accelerated approval pathways favor simple, cost-effective capsule formulations.
A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing.
September 02, 2020
End-user considerations are becoming increasingly important as they can provide a lot of value and help to ensure commercial success of a drug.